Clinical trial
A Phase I/II Study to Evaluate Single Agent and Combination Therapy With…
NCT00000737 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000737 |
|---|---|
| Title | A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome |
| Official title | A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Roxane Laboratories Industry Bristol-Myers Squibb |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cachexia, HIV Infections, HIV Wasting Syndrome |
| Intervention type | Drug |
| Interventions | Dronabinol, Megestrol acetate |
| Enrollment | 56 |
| First posted | Aug 31, 2001 |
| Last update posted | Aug 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: